Annual CFO
-$16.18 M
-$1.07 M-7.08%
December 31, 2023
Summary
- As of February 8, 2025, CYTH annual cash flow from operations is -$16.18 million, with the most recent change of -$1.07 million (-7.08%) on December 31, 2023.
- During the last 3 years, CYTH annual CFO has fallen by -$7.64 million (-89.52%).
- CYTH annual CFO is now -3008.36% below its all-time high of $556.50 thousand, reached on December 31, 2013.
Performance
CYTH Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$8.19 M
-$4.34 M-112.89%
September 30, 2024
Summary
- As of February 8, 2025, CYTH quarterly cash flow from operations is -$8.19 million, with the most recent change of -$4.34 million (-112.89%) on September 30, 2024.
- Over the past year, CYTH quarterly CFO has dropped by -$3.90 million (-90.75%).
- CYTH quarterly CFO is now -1789.15% below its all-time high of $485.00 thousand, reached on June 30, 2013.
Performance
CYTH Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$22.52 M
-$4.15 M-22.60%
September 30, 2024
Summary
- As of February 8, 2025, CYTH TTM cash flow from operations is -$22.52 million, with the most recent change of -$4.15 million (-22.60%) on September 30, 2024.
- Over the past year, CYTH TTM CFO has dropped by -$6.33 million (-39.13%).
- CYTH TTM CFO is now -3442.86% below its all-time high of $673.60 thousand, reached on September 30, 2013.
Performance
CYTH TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CYTH Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.1% | -90.8% | -39.1% |
| 3 y3 years | -89.5% | -90.8% | -39.1% |
| 5 y5 years | -407.6% | -90.8% | -39.1% |
CYTH Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -7.9% | at low | -213.7% | at low | -63.4% | at low |
| 5 y | 5-year | -145.6% | at low | -409.4% | at low | -241.7% | at low |
| alltime | all time | -3008.4% | at low | -1789.2% | at low | -3442.9% | at low |
Cyclo Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.19 M(+112.9%) | -$22.52 M(+22.6%) |
| Jun 2024 | - | -$3.85 M(-37.8%) | -$18.37 M(+2.1%) |
| Mar 2024 | - | -$6.18 M(+43.9%) | -$18.00 M(+11.2%) |
| Dec 2023 | -$16.18 M(+7.1%) | -$4.29 M(+6.3%) | -$16.18 M(+10.6%) |
| Sep 2023 | - | -$4.04 M(+16.2%) | -$14.64 M(+6.2%) |
| Jun 2023 | - | -$3.48 M(-20.4%) | -$13.78 M(-6.0%) |
| Mar 2023 | - | -$4.37 M(+59.1%) | -$14.65 M(-3.0%) |
| Dec 2022 | -$15.11 M(+0.7%) | -$2.75 M(-13.7%) | -$15.11 M(+0.9%) |
| Sep 2022 | - | -$3.18 M(-27.0%) | -$14.98 M(+1.0%) |
| Jun 2022 | - | -$4.36 M(-9.8%) | -$14.82 M(-0.6%) |
| Mar 2022 | - | -$4.83 M(+84.9%) | -$14.91 M(-0.6%) |
| Dec 2021 | -$15.01 M(+75.7%) | -$2.61 M(-13.7%) | -$15.01 M(-2.9%) |
| Sep 2021 | - | -$3.03 M(-31.8%) | -$15.45 M(+10.1%) |
| Jun 2021 | - | -$4.44 M(-9.9%) | -$14.04 M(+20.4%) |
| Mar 2021 | - | -$4.93 M(+60.9%) | -$11.66 M(+36.5%) |
| Dec 2020 | -$8.54 M(+29.6%) | -$3.06 M(+90.3%) | -$8.54 M(+10.9%) |
| Sep 2020 | - | -$1.61 M(-22.0%) | -$7.70 M(-0.2%) |
| Jun 2020 | - | -$2.06 M(+13.9%) | -$7.71 M(+7.5%) |
| Mar 2020 | - | -$1.81 M(-18.5%) | -$7.17 M(+8.9%) |
| Dec 2019 | -$6.59 M(+106.7%) | -$2.22 M(+36.8%) | -$6.59 M(+21.5%) |
| Sep 2019 | - | -$1.62 M(+6.7%) | -$5.42 M(+28.3%) |
| Jun 2019 | - | -$1.52 M(+24.2%) | -$4.23 M(+15.0%) |
| Mar 2019 | - | -$1.23 M(+16.2%) | -$3.68 M(+15.3%) |
| Dec 2018 | -$3.19 M(+4.1%) | -$1.05 M(+146.6%) | -$3.19 M(+2.2%) |
| Sep 2018 | - | -$427.70 K(-55.8%) | -$3.12 M(-4.6%) |
| Jun 2018 | - | -$968.40 K(+31.3%) | -$3.27 M(+25.0%) |
| Mar 2018 | - | -$737.70 K(-25.2%) | -$2.62 M(-14.6%) |
| Dec 2017 | -$3.06 M(+3.8%) | -$986.10 K(+70.5%) | -$3.06 M(+16.0%) |
| Sep 2017 | - | -$578.30 K(+84.5%) | -$2.64 M(-9.5%) |
| Jun 2017 | - | -$313.40 K(-73.5%) | -$2.92 M(-14.6%) |
| Mar 2017 | - | -$1.18 M(+109.9%) | -$3.42 M(+15.9%) |
| Dec 2016 | -$2.95 M(+48.3%) | -$564.40 K(-34.1%) | -$2.95 M(-8.1%) |
| Sep 2016 | - | -$856.30 K(+5.2%) | -$3.21 M(+13.8%) |
| Jun 2016 | - | -$813.60 K(+13.5%) | -$2.82 M(+20.2%) |
| Mar 2016 | - | -$716.70 K(-12.9%) | -$2.35 M(+18.0%) |
| Dec 2015 | -$1.99 M(+215.2%) | -$822.80 K(+76.2%) | -$1.99 M(+34.7%) |
| Sep 2015 | - | -$467.10 K(+37.2%) | -$1.48 M(+15.3%) |
| Jun 2015 | - | -$340.50 K(-5.2%) | -$1.28 M(+8.3%) |
| Mar 2015 | - | -$359.00 K(+15.6%) | -$1.18 M(+87.5%) |
| Dec 2014 | -$631.20 K(-213.4%) | -$310.60 K(+14.4%) | -$631.30 K(+40.3%) |
| Sep 2014 | - | -$271.50 K(+11.9%) | -$450.10 K(+393.0%) |
| Jun 2014 | - | -$242.70 K(-225.4%) | -$91.30 K(-114.3%) |
| Mar 2014 | - | $193.50 K(-249.5%) | $636.40 K(+14.4%) |
| Dec 2013 | $556.50 K(+851.3%) | -$129.40 K(-248.2%) | $556.50 K(-17.4%) |
| Sep 2013 | - | $87.30 K(-82.0%) | $673.60 K(+7.3%) |
| Jun 2013 | - | $485.00 K(+326.9%) | $627.80 K(+252.1%) |
| Mar 2013 | - | $113.60 K(-1023.6%) | $178.30 K(+204.8%) |
| Dec 2012 | $58.50 K | -$12.30 K(-129.6%) | $58.50 K(-62.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | $41.50 K(+16.9%) | $154.10 K(-10.3%) |
| Jun 2012 | - | $35.50 K(-672.6%) | $171.70 K(-5.7%) |
| Mar 2012 | - | -$6200.00(-107.4%) | $182.00 K(-2.0%) |
| Dec 2011 | $185.80 K(-11.5%) | $83.30 K(+40.9%) | $185.70 K(-31.9%) |
| Sep 2011 | - | $59.10 K(+29.0%) | $272.70 K(+71.0%) |
| Jun 2011 | - | $45.80 K(-1932.0%) | $159.50 K(-23.0%) |
| Mar 2011 | - | -$2500.00(-101.5%) | $207.20 K(-1.2%) |
| Dec 2010 | $209.90 K(+94.2%) | $170.30 K(-414.8%) | $209.80 K(+115.6%) |
| Sep 2010 | - | -$54.10 K(-157.9%) | $97.30 K(-48.8%) |
| Jun 2010 | - | $93.50 K(>+9900.0%) | $190.20 K(+86.1%) |
| Mar 2010 | - | $100.00(-99.8%) | $102.20 K(-5.5%) |
| Dec 2009 | $108.10 K(+67.1%) | $57.80 K(+49.0%) | $108.10 K(+3.1%) |
| Sep 2009 | - | $38.80 K(+605.5%) | $104.80 K(-9.4%) |
| Jun 2009 | - | $5500.00(-8.3%) | $115.70 K(+496.4%) |
| Mar 2009 | - | $6000.00(-89.0%) | $19.40 K(-70.0%) |
| Dec 2008 | $64.70 K(-82.5%) | $54.50 K(+9.7%) | $64.70 K(-58.0%) |
| Sep 2008 | - | $49.70 K(-154.7%) | $154.00 K(-17.3%) |
| Jun 2008 | - | -$90.80 K(-277.0%) | $186.30 K(-54.5%) |
| Mar 2008 | - | $51.30 K(-64.3%) | $409.50 K(+10.6%) |
| Dec 2007 | $370.20 K(+1318.4%) | $143.80 K(+75.4%) | $370.20 K(+60.2%) |
| Sep 2007 | - | $82.00 K(-38.1%) | $231.10 K(+9.2%) |
| Jun 2007 | - | $132.40 K(+1003.3%) | $211.70 K(+1175.3%) |
| Mar 2007 | - | $12.00 K(+155.3%) | $16.60 K(-36.4%) |
| Dec 2006 | $26.10 K(-79.7%) | $4700.00(-92.5%) | $26.10 K(-5.1%) |
| Sep 2006 | - | $62.60 K(-199.8%) | $27.50 K(+450.0%) |
| Jun 2006 | - | -$62.70 K(-391.6%) | $5000.00(-91.2%) |
| Mar 2006 | - | $21.50 K(+252.5%) | $56.90 K(-55.8%) |
| Dec 2005 | $128.80 K(-37.3%) | $6100.00(-84.8%) | $128.70 K(+23.0%) |
| Sep 2005 | - | $40.10 K(-471.3%) | $104.60 K(-39.9%) |
| Jun 2005 | - | -$10.80 K(-111.6%) | $174.00 K(+8.8%) |
| Mar 2005 | - | $93.30 K(-618.3%) | $160.00 K(-22.1%) |
| Dec 2004 | $205.40 K(+216.0%) | -$18.00 K(-116.4%) | $205.40 K(+0.9%) |
| Sep 2004 | - | $109.50 K(-541.5%) | $203.50 K(+51.5%) |
| Jun 2004 | - | -$24.80 K(-117.9%) | $134.30 K(-30.2%) |
| Mar 2004 | - | $138.70 K(-797.0%) | $192.50 K(+196.6%) |
| Dec 2003 | $65.00 K(+35.1%) | -$19.90 K(-149.4%) | $64.90 K(+32.4%) |
| Sep 2003 | - | $40.30 K(+20.7%) | $49.00 K(-29.9%) |
| Jun 2003 | - | $33.40 K(+200.9%) | $69.90 K(+51.3%) |
| Mar 2003 | - | $11.10 K(-131.0%) | $46.20 K(-4.0%) |
| Dec 2002 | $48.10 K(-305.6%) | -$35.80 K(-158.5%) | $48.10 K(-46.4%) |
| Sep 2002 | - | $61.20 K(+530.9%) | $89.70 K(+29.4%) |
| Jun 2002 | - | $9700.00(-25.4%) | $69.30 K(+566.3%) |
| Mar 2002 | - | $13.00 K(+124.1%) | $10.40 K(-144.4%) |
| Dec 2001 | -$23.40 K(-18.5%) | $5800.00(-85.8%) | -$23.40 K(-19.9%) |
| Sep 2001 | - | $40.80 K(-182.9%) | -$29.20 K(-58.3%) |
| Jun 2001 | - | -$49.20 K(+136.5%) | -$70.00 K(+236.5%) |
| Mar 2001 | - | -$20.80 K | -$20.80 K |
| Dec 2000 | -$28.70 K | - | - |
FAQ
- What is Cyclo Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Cyclo Therapeutics?
- What is Cyclo Therapeutics annual CFO year-on-year change?
- What is Cyclo Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Cyclo Therapeutics?
- What is Cyclo Therapeutics quarterly CFO year-on-year change?
- What is Cyclo Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Cyclo Therapeutics?
- What is Cyclo Therapeutics TTM CFO year-on-year change?
What is Cyclo Therapeutics annual cash flow from operations?
The current annual CFO of CYTH is -$16.18 M
What is the all time high annual CFO for Cyclo Therapeutics?
Cyclo Therapeutics all-time high annual cash flow from operations is $556.50 K
What is Cyclo Therapeutics annual CFO year-on-year change?
Over the past year, CYTH annual cash flow from operations has changed by -$1.07 M (-7.08%)
What is Cyclo Therapeutics quarterly cash flow from operations?
The current quarterly CFO of CYTH is -$8.19 M
What is the all time high quarterly CFO for Cyclo Therapeutics?
Cyclo Therapeutics all-time high quarterly cash flow from operations is $485.00 K
What is Cyclo Therapeutics quarterly CFO year-on-year change?
Over the past year, CYTH quarterly cash flow from operations has changed by -$3.90 M (-90.75%)
What is Cyclo Therapeutics TTM cash flow from operations?
The current TTM CFO of CYTH is -$22.52 M
What is the all time high TTM CFO for Cyclo Therapeutics?
Cyclo Therapeutics all-time high TTM cash flow from operations is $673.60 K
What is Cyclo Therapeutics TTM CFO year-on-year change?
Over the past year, CYTH TTM cash flow from operations has changed by -$6.33 M (-39.13%)